6-(4-Amino-3,5-dimethyl-phenyl)-8-(3-bromo-4,5-dihydro-isoxazol-5-ylmethyl)-2,3,8,10-tetrahydro-1,4-dioxa-7,8-diaza-cyclohepta[b]naphthalen-9-one

ID: ALA4071408

Chembl Id: CHEMBL4071408

PubChem CID: 137638800

Max Phase: Preclinical

Molecular Formula: C23H23BrN4O4

Molecular Weight: 499.37

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(C2=NN(CC3CC(Br)=NO3)C(=O)Cc3cc4c(cc32)OCCO4)cc(C)c1N

Standard InChI:  InChI=1S/C23H23BrN4O4/c1-12-5-15(6-13(2)22(12)25)23-17-10-19-18(30-3-4-31-19)7-14(17)8-21(29)28(26-23)11-16-9-20(24)27-32-16/h5-7,10,16H,3-4,8-9,11,25H2,1-2H3

Standard InChI Key:  AUEHVKZCUPPOIK-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4071408

    ---

Associated Targets(Human)

GRIA4 Tclin Glutamate receptor ionotropic, AMPA 4 (256 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIA3 Tclin Glutamate receptor ionotropic, AMPA 3 (127 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIA1 Tclin Glutamate receptor ionotropic, AMPA 1 (277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIA2 Tclin Glutamate receptor ionotropic, AMPA 2 (847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 499.37Molecular Weight (Monoisotopic): 498.0903AlogP: 3.29#Rotatable Bonds: 3
Polar Surface Area: 98.74Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.02CX LogP: 3.33CX LogD: 3.33
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.65Np Likeness Score: -0.30

References

1. Espahbodinia M, Ettari R, Wen W, Wu A, Shen YC, Niu L, Grasso S, Zappalà M..  (2017)  Development of novel N-3-bromoisoxazolin-5-yl substituted 2,3-benzodiazepines as noncompetitive AMPAR antagonists.,  25  (14): [PMID:28571973] [10.1016/j.bmc.2017.05.036]

Source